Condition: Beta-Thalassemia · Sponsor: Children's Hospital of Fudan University
This is a study to evaluate the long-term safety and efficacy of CS-101 in participants who received CS-101 in study CS -101-03 (NCT06065189)
This description comes directly from the study's public registry record.
Xiaowen Zhai, M.D. · +86-021-64931126 · zhaixiaowendy@163.com
Zifeng Li, M.S. · +86-13920704768 · zfli18@fudan.edu.cn
Always discuss trial participation with your own doctor first.
| Children's Hospital of Fudan University | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06479616